1099 — Sinopharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual balance sheet for Sinopharm Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	50,217	43,541	55,327	63,814	54,314
Net Total Accounts Receivable
Net Total Receivables	149,448	176,273	175,733	189,797	201,479
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	267,610	290,922	319,406	336,835	347,448
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18,896	19,408	19,647	19,898	19,632
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	311,237	335,412	364,775	383,395	392,831
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	203,977	219,307	234,963	241,491	250,376
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	254,878	273,526	296,707	308,813	313,947
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	56,359	61,886	68,069	74,582	78,884
Total Liabilities & Shareholders' Equity	311,237	335,412	364,775	383,395	392,831
Total Common Shares Outstanding